Laboratory of Bacteriology, Butantan Institute, São Paulo, Brazil.
Department of Microbiology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
mBio. 2020 Apr 14;11(2):e00617-20. doi: 10.1128/mBio.00617-20.
The translocation of effectors into the host cell through type 3 secretion systems (T3SS) is a sophisticated strategy employed by pathogenic bacteria to subvert host responses and facilitate colonization. Enteropathogenic (EPEC) and enterohemorrhagic (EHEC) utilize the Tir and EspFu (also known as TccP) effectors to remodel the host cytoskeleton, culminating in the formation of attaching and effacing (AE) lesions on enterocytes. While some EPEC strains require tyrosine phosphorylation of Tir and recruitment of the host Nck to trigger actin polymerization, EHEC and certain EPEC strains, whose Tir is not phosphorylated, rely on the effector EspFu for efficient actin remodeling. Here, we investigated the role played by Tir-Nck and Tir-EspFu actin polymerization pathways during the infection of epithelial cells, as well as the host transcriptional response to the AE lesion formation induced by EPEC. We found that EspFu-mediated actin assembly promotes bacterial attachment and epithelial colonization more efficiently than Tir-Nck. Moreover, we showed that both actin polymerization mechanisms can activate inflammatory pathways and reverse the anti-inflammatory response induced by EPEC in epithelial cells. However, this activity is remarkably more evident in infections with EspFu-expressing EPEC strains. This study demonstrates the complex interactions between effector-mediated actin remodeling and inflammation. Different strains carry different combinations of these two effectors, highlighting the plasticity of pathogenic enteric infections. EPEC is among the leading causes of diarrheal disease worldwide. The colonization of the gut mucosa by EPEC results in actin pedestal formation at the site of bacterial attachment. These pedestals are referred to as attaching and effacing (AE) lesions. Here, we exploit the different molecular mechanisms used by EPEC to induce AE lesions on epithelial cells, showing that the effector EspFu is associated with increased bacterial attachment and enhanced epithelial colonization compared to the Tir-Nck pathway. Moreover, we also showed that actin pedestal formation can counterbalance the anti-inflammatory activity induced by EPEC, especially when driven by EspFu. Collectively, our findings provide new insights into virulence mechanisms employed by EPEC to colonize epithelial cells, as well as the host response to this enteric pathogen.
效应蛋白通过 III 型分泌系统(T3SS)易位进入宿主细胞是一种复杂的策略,被致病性细菌用来颠覆宿主反应并促进定植。肠致病性大肠杆菌(EPEC)和肠出血性大肠杆菌(EHEC)利用 Tir 和 EspFu(也称为 TccP)效应蛋白重塑宿主细胞骨架,最终导致肠上皮细胞形成附着和消除(AE)病变。虽然一些 EPEC 菌株需要 Tir 的酪氨酸磷酸化和宿主 Nck 的募集来触发肌动蛋白聚合,但 EHEC 和某些未磷酸化 Tir 的 EPEC 菌株依赖效应蛋白 EspFu 来有效进行肌动蛋白重塑。在这里,我们研究了 Tir-Nck 和 Tir-EspFu 肌动蛋白聚合途径在感染上皮细胞过程中的作用,以及宿主对 EPEC 诱导的 AE 病变形成的转录反应。我们发现,EspFu 介导的肌动蛋白组装比 Tir-Nck 更有效地促进细菌附着和上皮定植。此外,我们表明,这两种肌动蛋白聚合机制都可以激活炎症途径,并逆转 EPEC 在上皮细胞中诱导的抗炎反应。然而,这种活性在感染表达 EspFu 的 EPEC 菌株时更为明显。这项研究证明了效应蛋白介导的肌动蛋白重塑与炎症之间的复杂相互作用。不同的菌株携带这两种效应蛋白的不同组合,突出了肠道致病性感染的可塑性。EPEC 是全世界导致腹泻疾病的主要原因之一。EPEC 在肠道黏膜的定植导致细菌附着部位形成肌动蛋白足。这些足被称为附着和消除(AE)病变。在这里,我们利用 EPEC 诱导上皮细胞形成 AE 病变的不同分子机制,表明与 Tir-Nck 途径相比,效应蛋白 EspFu 与增加的细菌附着和增强的上皮定植相关。此外,我们还表明,肌动蛋白足的形成可以抵消 EPEC 诱导的抗炎活性,尤其是在 EspFu 驱动时。总的来说,我们的研究结果为 EPEC 定植上皮细胞所采用的毒力机制以及宿主对这种肠道病原体的反应提供了新的见解。